KeyBioscience AG: Clinical Trials

2 trials sponsored by KeyBioscience AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow KeyBioscience AG: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
KBP-336, Placebo - Osteoarthritis in the Knee, Obesity
Phase 2RecruitingKeyBioscience AG6002025-01-282025-02-19
Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Daily injection of KBP/placebo for 12 weeks as add-on to metformin - Type 2 Diabetes Mellitus
Phase 2CompletedKeyBioscience AG2552017-08-232018-09-11

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Osteoarthritis (1)  ·  Pain (1)

Countries

Czechia (2)  ·  Denmark (2)  ·  Moldova (2)  ·  Poland (2)  ·  Romania (2)  ·  Hong Kong (1)  ·  United Kingdom (1)

NIH funding

2017 (1)